- Latest week
- 10 Jul 2026
- Close
- 27.740000
- Fair value
- 14.099199
- Next-week expectancy
- Undecided 48.33%
ARQT Chart Pack
Arcutis Biotherapeutics Inc
Chart Summary
Over the latest 12 completed weeks ending 2026-07-10, ARQT rose 19.26%, moving from 23.26 to 27.74. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is 3.80 and has improved across the 12-week window. Market Dynamics is 0.97 on the latest week. Next-week expectancy is undecided at 48.33% based on similar historical setup states.
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 27.74
- 12-Week Change
- 19.26%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Undecided 48.33%
- Signal Weeks
- 0 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- 3.80
- Market Dynamics
- 0.97
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 27.74
- 12-Week Change
- 19.26%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Undecided 48.33%
- Signal Weeks
- 0 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- 3.80
- Market Dynamics
- 0.97
Over the latest 12 completed weeks ending 2026-07-10, ARQT rose 19.26%, moving from 23.26 to 27.74. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is 3.80 and has improved across the 12-week window. Market Dynamics is 0.97 on the latest week. Next-week expectancy is undecided at 48.33% based on similar historical setup states.
Industry Peers
United States equities in Biotechnology
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| FBRX Forte Biosciences Inc | NASDAQ | 10 Jul 2026 | 20.81 | 45.36 | 19.95 | 43.92 | 111.05% |
| CRNX Crinetics Pharmaceuticals Inc | NASDAQ | 10 Jul 2026 | 42.03 | 83.76 | 41.39 | 83.58 | 98.86% |
| TRAX First Tracks Biotherapeutics | NASDAQ | 10 Jul 2026 | 19.23 | 38.49 | 18.49 | 36.24 | 88.46% |
| TVRD Tvardi Therapeutics, Inc. | NASDAQ | 10 Jul 2026 | 1.95 | 5.69 | 1.95 | 3.28 | 68.21% |
| CBUS Cibus Global LLC | NASDAQ | 10 Jul 2026 | 1.39 | 2.20 | 1.36 | 2.02 | 45.32% |
| AKTX Akari Therapeutics PLC | NASDAQ | 10 Jul 2026 | 9.80 | 15.50 | 9.80 | 13.88 | 41.63% |
| VRAX Virax Biolabs Group Limited Ordinary Shares | NASDAQ | 10 Jul 2026 | 2.95 | 13.19 | 2.84 | 4.08 | 38.31% |
| AARD Aardvark Therapeutics, Inc. Common Stock | NASDAQ | 10 Jul 2026 | 5.59 | 7.92 | 4.66 | 7.60 | 35.96% |
| MSLE Satellos Bioscience Inc. Common Stock | NASDAQ | 10 Jul 2026 | 7.32 | 10.00 | 7.32 | 9.79 | 33.74% |
| TTRX Turn Therapeutics Inc. Common Stock | NASDAQ | 10 Jul 2026 | 7.18 | 11.69 | 7.10 | 9.44 | 31.48% |
| PEPG PepGen Ltd | NASDAQ | 10 Jul 2026 | 1.78 | 2.44 | 1.77 | 2.34 | 31.46% |
| CUE Cue Biopharma | NASDAQ | 10 Jul 2026 | 28.01 | 45.50 | 28.01 | 36.78 | 31.31% |
| LRMR Larimar Therapeutics Inc | NASDAQ | 10 Jul 2026 | 3.29 | 4.32 | 3.21 | 4.28 | 30.09% |
| JSPR Jasper Therapeutics Inc | NASDAQ | 10 Jul 2026 | 0.45 | 0.68 | 0.42 | 0.58 | 29.04% |
| MTVA MetaVia Inc. | NASDAQ | 10 Jul 2026 | 1.41 | 1.80 | 1.41 | 1.78 | 26.24% |
| VSTM Verastem Inc | NASDAQ | 10 Jul 2026 | 4.52 | 5.57 | 4.30 | 5.53 | 22.35% |